Government experts believe there is still a risk of people contracting variant Creutzfeldt-Jakob Disease (vCJD) through blood transfusions. "There needs to be blood testing to answer this question of prevalence properly," said Professor John Collinge (UCL Neurodegenerative Diseases).
Read: Telegraph
Close
